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Tariq Siddiqui ( Department of Medicine, The Aga Khan University Hospital, Karachi. ) 
Gingival hypertrophy occurs in some cases of acute leukemia. Most commonly, this association is with
acute monocy tic and rnyelomonocytic leukemia1. We report a case of gingival hypertrophy and
hypothesize some reasons to explain such an occurrence in acute megakaiyocytic disease.
Case Report 
A 32 yearold previously healthy womanpresentedto the University Hospital of Jacksonville (Florida)
with a three week histoiy of weakness, low grade fever, shortness of breath and easy bruising. There
was no history of medication or illicit drug usage, allergies, or any important facts in her family history.
The menstrual history was normal except for recent metromenorrhagia. She had given birth to two
children aged 5 and 7 who were in good health. Physical examination revealed a well developed, well
nourished, moderately obese black woman with normal vital signs. The gingiva showed marked
hypertrophy and inflammation (Figure 1).
Multiple ecchymoses were present on the extremities. The lungs were clear and the cardiac
examination was normal. There was no palpable abdominal organomegaly and the patient was intact
neurologically. Laboratory findings revealed WBC 2.7x103U1, RBC 3.lxlO /pi, Hgb 9.0 gm/dl, Hct
28%, reticulocyte count 6.1%, platelet count 14x1034/U. Differential WBC count showed neutrophils
8%, bands 2%, lymphocytes 74%, monocytes 11% and atypical lymphocytes 5%. The peripheral blood
smear demonstrated abundant nucleated red cells (NRBC) (35 NRBC/l00 WBC), anisocytosis and an
occasional white cell with an inunature nuclear pattern. Other laboratory tests including direct and
indirect Coombs test were negative. Cytomegalovirus titer was 1:16. Prothmmbin and partial
thromboplastin time was normal; total serum protein 7.4 gms/dl; albumin 4.0 gni/dl; normal liver
function tests; serum iron 54; transferrin 188; serum ferritin 238. Serum 1gM 572; IgG 1560. HIV
serology test by ELISA was negative. Urine and blood cultures were negative. A bone macrow aspirate
was performed with a "dry" aspirate and the biopsy revealed myelofibrosis with areas of
undifferentiated atypical megakaryocyles consistent with acute megakaiyoblasiic leukemia.
Immunoperoxidase stain for Factor VIII related antigen demonstrated positivity both in the abnonnal
cells and the large undifferentiated cells consistent with a megakaryocytic lineage. Many of the smaller
cells in clusters also stained positive and these were also morphologically recognizable as
megakaryocytes. There were however no recognizable myeloid or crythmid precursors in the bone
marrow. Chromosome analysis done on the peripheral blood showed a normal female kaiyotype (46
XX) based on an analysis of 20 metaphase cells examined from 24 hours of unstained peripheral cell
culture. A chromosome analysis performed on bone marrow cultures failed. Radiographs of the
sternum, pelvis, skull and chest were normal. Computerized tomography of the abdomen was normal
with no evidence of hepatosplenomegaly. The patient was treated with supportive therapy including
platelet and red blood cell transfusions. Because of the known poor prognosis in megakaryoblastic
leukemia, the patient underwent an HLA identical sibling related bone marrow transplant. The patient
unfortunately succumbed during the transplant confinement to infectious complications.
Discussion 
A number of clinical conditions can be associated with gingival hypertrophy. These include
pregnancy2,3, drugs such as dilantin, cyclosporine and nifedipine4,5, other rare conditions6 and non-
malignant heniatologic disease may also cause gingival hypertrophy7,8. Oral manifestations of acute
leukemia are well recognized clinically. These manifestations include bleeding from the mouth, but in
some cases marked hypertrophy of the gingiva also occurs. Hypertrophy of the gums is thus an
interesting physical finding in acute leukemia but its clinical significance is dubious. This is usually
ascribed to infiltration of the area with neoplastic cells and parallels the hematologic course of the acute
leukemia9-11. In 1958 Duffy described the oral manifestation in 38 cases of leukemia and of these, 17
patients had gingival hypertrophy. No hematologic subtype of the leukemias were however descnbed.
Gingival hypertrophy has been described in the acute monocytic, myclomonocytic, rnyelocytic11, but
to our knowledge not in acute megakaryocytic leukemia and or the related entity of acute
myelofibrosis. A number of publications have expanded this clinical spectrum which remains closely
related and inter-twined with acute megakaryoblastic leukemia. Acute megakazyoblastic leukemia
belongs to the M-7 category of the FAB classification of the acute leukemias. Acute megakazyoblastic
leukemia is rare and accounts for only 1% of all the cases of AML12. The M-7 subset of acute myeloid
leukemia has admittedly been a difficult diagnosis in the past and has been the subject of some
hematologic difficulty because of vatying diagnostic criteria which are employed. In order to diagnose
this entity, one needs the appropriate bone marrow findings and other corroborative immunochemical
evidence e.g., a demonstration of factor VIII related antigen in the blasts and or other tests if available.
A significant finding which is observed in the M7 FAB subset of acute myeloid leukemia cases is bone
marrow fibrosis12,13. These patients are often pancytopenic and both the bone marrow and the
peripheral blood contains few cells. It is believed on the basis of clinical and experimental evidence
that this bone marrow fibrosis is related to the secretion of multiple growth factors by the
megakamyocytic cells line. In a recent paper Teriui showed that megakaryoblasts from a patient with
leukemia secreted transforming growth factor beta (TGFB)14. TGFB in this patient stimulated the
production of collagen from the bone marrow fibroblasts. TGFB is a substance of diverse activity
whose functions include cellular suppression and fibrous tissue deposition. Platelet also release other
substances e.g.. platelet derived growth factors which could be related etiologically to bone marrow
fibrosis as well. Altered collagen metabolism has been reported in nifedipine induced gingival
overgrowth as well15. If as we feel, that our patient’s gingival enlargement was not due to cellular
infiltration, then its explanation may be in the ability of the leukemic cell line to cause gingival
hypertrophy. It is unlikely that cellular infiltration was the cause of this finding because the patient had
bone marrow fibrosis, hypocellularity and importantly severe peripheral pancytopenia. It is possible
that growth factors secreted by the malignant megakaryocytic cell line could affect the gingiva either
systemically or due to the local proximity of the gingiva to the leukemia in the facial and jaw bones.
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